| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function
|
Maimaitili, Yimamu
|
|
2018
|
74 |
C |
p. 68-74
|
artikel
|
| 2 |
A phase I clinical trial of ruxolitinib in combination with nilotinib in chronic myeloid leukemia patients with molecular evidence of disease
|
Sweet, Kendra
|
|
2018
|
74 |
C |
p. 89-96
|
artikel
|
| 3 |
CD34+ chimerism analysis for minimal residual disease monitoring after allogeneic hematopoietic cell transplantation
|
Unnikrishnan, Athira
|
|
2018
|
74 |
C |
p. 110-112
|
artikel
|
| 4 |
Clustered incidence of adult acute promyelocytic leukemia
|
Brunner, Andrew M.
|
|
2018
|
74 |
C |
p. 47-50
|
artikel
|
| 5 |
CPX-351 exhibits hENT-independent uptake and can be potentiated by fludarabine in leukaemic cells lines and primary refractory AML
|
Anderson, Elizabeth
|
|
2018
|
74 |
C |
p. 121-129
|
artikel
|
| 6 |
Does switching to a second-generation tyrosine kinase inhibitor or increasing imatinib dose have long-term benefits in chronic myeloid leukemia patients with suboptimal responses under upfront standard-dose of imatinib?
|
Eskazan, Ahmet Emre
|
|
2018
|
74 |
C |
p. 55-56
|
artikel
|
| 7 |
Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients
|
Palandri, Francesca
|
|
2018
|
74 |
C |
p. 86-88
|
artikel
|
| 8 |
Editorial Board
|
|
|
2018
|
74 |
C |
p. ii
|
artikel
|
| 9 |
Expression of the miR-150 tumor suppressor is restored by and synergizes with rapamycin in a human leukemia T-cell line
|
Podshivalova, Katie
|
|
2018
|
74 |
C |
p. 1-9
|
artikel
|
| 10 |
Incorporating newer agents in the treatment of acute myeloid leukemia
|
Raj, Renju V.
|
|
2018
|
74 |
C |
p. 113-120
|
artikel
|
| 11 |
Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review study
|
Matsuda, Akira
|
|
2018
|
74 |
C |
p. 137-143
|
artikel
|
| 12 |
Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS
|
Leitch, Heather A.
|
|
2018
|
74 |
C |
p. 21-41
|
artikel
|
| 13 |
Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS study
|
Birgegård, Gunnar
|
|
2018
|
74 |
C |
p. 105-109
|
artikel
|
| 14 |
NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells
|
Hishiki, Kotaro
|
|
2018
|
74 |
C |
p. 57-63
|
artikel
|
| 15 |
Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow
|
Jamy, Omer
|
|
2018
|
74 |
C |
p. 64-67
|
artikel
|
| 16 |
Pharmacogenomics and variations in the risk of toxicity during the consolidation/maintenance phases of the treatment of pediatric B-cell leukemia patients from an admixed population in the Brazilian Amazon
|
de Carvalho, Darlen Cardoso
|
|
2018
|
74 |
C |
p. 10-13
|
artikel
|
| 17 |
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma
|
Radivoyevitch, Tomas
|
|
2018
|
74 |
C |
p. 130-136
|
artikel
|
| 18 |
Role of radiotherapy in patients with limited diffuse large B-cell lymphoma of Waldeyer's ring in remission after R-CHOP immunochemotherapy
|
Li, Chunyan
|
|
2018
|
74 |
C |
p. 80-85
|
artikel
|
| 19 |
RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice
|
Nakamura, Yuka
|
|
2018
|
74 |
C |
p. 14-20
|
artikel
|
| 20 |
Safety and efficacy of switching from branded to generic imatinib in chronic phase chronic myeloid leukemia patients treated in Italy
|
Bonifacio, Massimiliano
|
|
2018
|
74 |
C |
p. 75-79
|
artikel
|
| 21 |
TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid
|
Chong, Mei-Ling
|
|
2018
|
74 |
C |
p. 51-54
|
artikel
|
| 22 |
TLE1 as an indicator of adverse prognosis in pediatric acute lymphoblastic leukemia
|
Brassesco, María Sol
|
|
2018
|
74 |
C |
p. 42-46
|
artikel
|
| 23 |
TP53 mutation in allogeneic hematopoietic cell transplantation for de novo myelodysplastic syndrome
|
Kim, Yoo-Jin
|
|
2018
|
74 |
C |
p. 97-104
|
artikel
|
Tijdschrift beschrijving